Codem, Immune Checkpoint Inhibitor Theme Rises 7.27%

On the 5th, the immuno-oncology theme rose 3.01% compared to the previous day, showing strength, while Codem, a related stock attracting attention, surged 7.27% compared to the previous day. Codem is known as a semiconductor and display manufacturing equipment company.

[Graph] Price changes of major stocks in the immuno-oncology theme



According to preliminary data compiled at 10:24, foreigners are buying 542,600 shares of Codem, indicating a large net purchase by foreign investors.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)



According to the analysis by Thinkpool Robo Algorithm RASSI, Codem’s quant financial score is 7.19 points, which is lower in stability, profitability, and growth compared to the average of other stocks related to immuno-oncology. This can be interpreted as Codem having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, Dong-A ST ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of the robo algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.